376 related articles for article (PubMed ID: 7927218)
1. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
Park BC; Huh MH; Seo JH
J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
[TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
Seo JH; Park BC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
[TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
[TBL] [Abstract][Full Text] [Related]
5. [Expression of c-myc, c-erbB-2, insulin-like growth factor II andepidermal growth factor receptor in hepatitis B, cirrhosis and hepatocellular carcinoma].
Su Q; Liu Y
Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):144-6, 189. PubMed ID: 7780818
[TBL] [Abstract][Full Text] [Related]
6. [The determination of the viral markers of the hepatitis B virus and protein p53 in liver biopsy samples].
Lörinczi L; Székely E
Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):161-6. PubMed ID: 9932005
[TBL] [Abstract][Full Text] [Related]
7. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
Seo JH; Kim KW; Murakami S; Park BC
J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
[TBL] [Abstract][Full Text] [Related]
8. Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues.
Negro F; Papotti M; Taraglio S; Rubbia-Brandt L; Giostra E; Pacchioni D; Rizzetto M; Hadengue A
J Viral Hepat; 1997 Mar; 4(2):93-8. PubMed ID: 9097264
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.
Hsu DK; Dowling CA; Jeng KC; Chen JT; Yang RY; Liu FT
Int J Cancer; 1999 May; 81(4):519-26. PubMed ID: 10225438
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response.
Jacob JR; Ascenzi MA; Roneker CA; Toshkov IA; Cote PJ; Gerin JL; Tennant BC
Hepatology; 1997 Dec; 26(6):1607-15. PubMed ID: 9398005
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the expression of IGF-2 and HBxAg in human hepatocellular carcinoma and liver cirrhosis].
Zhang JF; Liu YF; Su Q
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):282-4. PubMed ID: 7874760
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship to liver cell dysplasia.
Omata M; Mori J; Yokosuka O; Iwama S; Ito Y; Okuda K
Liver; 1982 Jun; 2(2):125-32. PubMed ID: 6294442
[TBL] [Abstract][Full Text] [Related]
13. [Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma].
Su Q; Liu Y
Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):93-5. PubMed ID: 7788735
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases.
Jin YM; Yun C; Park C; Wang HJ; Cho H
J Viral Hepat; 2001 Sep; 8(5):322-30. PubMed ID: 11555189
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and chronic persistent hepatitis.
Shikata T; Yamazaki S; Uzawa T
Acta Pathol Jpn; 1977 May; 27(3):297-304. PubMed ID: 200057
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.
Iwai M; Kashiwadani M; Okuno T; Takino T; Ibata Y
Histochem J; 1988 May; 20(5):283-9. PubMed ID: 2850288
[TBL] [Abstract][Full Text] [Related]
17. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis].
Fan Z; Yang D; Qin H
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.
Niu Y; Wu Z; Shen Q; Song J; Luo Q; You H; Shi G; Qin W
Dig Liver Dis; 2013 Dec; 45(12):1041-8. PubMed ID: 23891548
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: relationship to fatty change in carcinoma cells.
Sohda T; Kamimura S; Iwata K; Shijo H; Okumura M
J Gastroenterol Hepatol; 1997 Mar; 12(3):224-8. PubMed ID: 9142639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
